The glucagonoma syndrome and its management

Journal of Surgical Oncology

Volumn 9, Issue 5, 1977, Pages 419-424

  Kessinger, Anne ^a   Lemon, Henry M ^a   Foley, John F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

glucagonoma syndrome; islet cell carcinoma

Indexed keywords

DACARBAZINE; GLUCOSE; STREPTOZOCIN;

AMINO ACID BLOOD LEVEL; CANCER THERAPY; DRUG THERAPY; GLUCAGON RELEASE; GLUCAGONOMA; GLUCOSE TOLERANCE TEST; HYPERGLUCAGONEMIA; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; METASTASIS; PANCREAS ISLET CELL CARCINOMA; PANCREAS ISLET CELL TUMOR; RASH; THERAPY;

ADENOMA, ISLET CELL; ADULT; AGED; CASE REPORT; DERMATITIS; DIABETES MELLITUS; FEMALE; GLUCAGON; HUMAN; MALE; MIDDLE AGE; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; SYNDROME;

EID: 0017699645     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.2930090502     Document Type: Article

References (23)

1. The many faces of islet cell tumors
2. Cutaneous manifestations of internal malignant tumors
3. An enteroglucagon tumor
4. A cutaneous syndrome associated with islet cell carcinoma of the pancreas
5. Elevated plasma proglucagon‐like component with a glucagon‐secreting tumor. Effect of streptozotocin
6. Endocrine tumor in kidney affecting small bowel structure, motility and absorptive function
7. Metastasierendes Inselzell Karzinom vom A‐Zell typ bei einem Fall von Pemphigus foliaceus mit Diabetes renalis
8. Metabolic studies in the malignant glucagonoma syndrome
9. Serial morphologic changes in rabbit pancreatic islet cells after streptozotocin
10. Inhibitory action of somatostatin on pancreatic alpha and beta cell function
11. Endocrine syndromes associated with pancreatic islet cell tumors
12. A glucagonoma syndrome
13. Glucagon levels and metabolic effects in fasting man
14. A glucagon‐secreting alpha cell carcinoma of the pancreas
15. Treatment of multiple islet cell tumor with streptozotocin
16. Secretion of various endocrine substances by ACTH‐secreting tumors ‐ gastrin, serotonin, parathormone, vasopressin, glucagon
17. The APUD cell concept and its implications in pathology
18. Pancreatic glucagonoma: a clinical‐angiographic correlation
19. Distribution of plasma glucagon immuno‐reactivity in a patient with suspected glucagonoma
20. Necrolytic migratory erythema with glucagon‐secreting tumor of the pancreas
21. Increased circulating large glucagon immuno‐reactivity in the glucagonoma syndrome
22. Necrolytic migratory erythema with pancreatic carcinoma